U.S. market Closed. Opens in 11 hours 44 minutes

ADPT | Adaptive Biotechnologies Corporation Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue170.28M185.31M154.34M98.38M85.07M55.66M38.45M
Cost of Revenue97.78M57.91M49.30M22.53M22.27M19.67M15.68M
Gross Profit72.49M127.40M105.04M75.85M62.80M35.99M22.77M
Operating Expenses274.10M327.58M314.01M228.67M141.19M85.75M66.40M
Selling, General & Admin172.51M184.13M169.97M110.89M68.78M44.90M32.71M
Research & Development101.58M141.76M142.34M116.07M70.70M39.16M32.00M
Other Operating Expenses27.13M1.70M1.70M1.70M1.70M1.70M1.69M
Operating Income-201.61M-200.19M-208.97M-152.82M-78.39M-49.76M-44.48M
Other Expenses / Income-23.70M-182.00K1.67M6.59M9.79M3.31M1.64M
Before Tax Income-225.30M-200.37M-207.30M-146.23M-68.61M-46.45M-42.83M
Income Tax Expenses-54.00K-57.90M-1.69M-6.59M-9.79M3.31MN/A
Net Income-225.25M-142.46M-205.61M-139.64M-58.82M-46.45M-42.83M
Interest Expenses13.80M4.24MN/AN/AN/AN/AN/A
Basic Shares Outstanding144.38M142.52M140.35M131.22M69.17M105.43M105.88M
Diluted Shares Outstanding144.38M142.52M140.35M131.22M69.17M105.43M105.88M
EBITDA-179.38M-194.43M-207.27M-151.11M-76.69M-43.76M-37.03M
EBITDA Margin-105.34%-104.92%-134.29%-153.60%-90.15%-78.61%-96.32%
EBIT-211.50M-196.13M-207.30M-146.23M-68.61M-43.14M-42.83M
EBIT Margin-124.21%-105.84%-134.31%-148.63%-80.65%-77.50%-111.40%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙